Managing Partner, Harris Kaplan, published in Forbes: The Importance Of Being An Optimistic Realist In Biotech Investing

Harris Kaplan, Managing Partner, just published an article in Forbes, The Importance Of Being An Optimistic Realist In Biotech Investing. Investors in biotech need to be optimistic realists. They need to consider and balance two views of every investment: the optimism of the new and exciting science with the realism that there’s a low probability the science will translate into successful products. Take a read for Harris' take on how to be a successful optimistic realist.